JAMA· 2026
Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain
- 0citations
- 2026year
Short summary
Unapproved GLP-1 drugs retatrutide and zenagamtide are being sold online, posing significant risks to consumers.
AI-generated from the title and abstract; the full text is not read.
Key points
- Unapproved GLP-1 drugs retatrutide and zenagamtide are widely available online.
- These drugs are often sold through social media platforms and unregulated online pharmacies.
- Potential risks include counterfeit products, contamination, and incorrect dosages.
- Consumers are advised to avoid these unapproved medications due to significant health dangers.
AI-generated from the title and abstract; the full text is not read.
Abstract
This Medical News article discusses the reasons behind the burgeoning black market for 2 unapproved GLP-1 weight loss drugs and the potential risks associated with their use.
The authors' abstract, as published at the source. JAMA, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Public Health, Environmental and Occupational Health
Public Health, Environmental and Occupational HealthMedicine